Swiss National Bank Roivant Sciences Ltd. Transaction History
Swiss National Bank
- $146 Billion
- Q4 2024
A detailed history of Swiss National Bank transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Swiss National Bank holds 727,246 shares of ROIV stock, worth $7.75 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
727,246
Previous 721,046
0.86%
Holding current value
$7.75 Million
Previous $8.32 Million
3.4%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$701 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$662 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$510 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$470 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$377 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.51B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...